These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1266836)

  • 1. Therapy with gastrin antibody in the Zollinger-Ellison syndrome.
    Hughes WS; Hughes JB; Ritzmann SE
    Am J Dig Dis; 1976 Mar; 21(3):201-4. PubMed ID: 1266836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
    Jansen JB; Lamers CB
    Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of serum gastrin levels in Zollinger-Ellison syndrome. Studies with two antisera to gastrin.
    Ivey KJ; Hansky J
    Am J Dig Dis; 1975 Jun; 20(6):513-17. PubMed ID: 1130377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
    Ippoliti AF; Isenberg JI; Hagie L
    Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a gastrin-receptor antagonist on gastric acid secretion and serum gastrin in the Zollinger-Ellison syndrome.
    Lamers CB; Jansen JB
    J Clin Gastroenterol; 1983 Feb; 5(1):21-4. PubMed ID: 6841943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of stress on serum gastrin in Zollinger-Ellison syndrome.
    Nomura T; Fukudo S; Muranaka M; Iwahashi S; Sasaki M; Satake M; Sasaki I; Shibata C; Matsuno S
    Am J Gastroenterol; 1993 Sep; 88(9):1432-5. PubMed ID: 8362843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metiamide in the Zollinger-Ellison syndrome.
    Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome.
    Collen MJ; Jensen RT
    Dig Dis Sci; 1994 Jul; 39(7):1434-40. PubMed ID: 8026253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parietal cell autoantibodies and hypergastrinemia in achlorhydria and the Zollinger-Ellison syndrome.
    Turnipseed WD; Keith LM; Sparks J
    Am J Surg; 1979 Feb; 137(2):213-5. PubMed ID: 426178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay.
    Dockray GJ; Taylor IL
    Gastroenterology; 1976 Dec; 71(6):971-7. PubMed ID: 992280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.
    Blonski WC; Katzka DA; Lichtenstein GR; Metz DC
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):441-4. PubMed ID: 15756097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucagon on serum gastrin. II. Studies in pernicious anaemia and the Zollinger-Ellison syndrome.
    Korman MG; Soveny C; Hansky J
    Gut; 1973 Jun; 14(6):459-61. PubMed ID: 4719212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome.
    Mihas AA; Hirschowitz BI; Gibson RG
    Digestion; 1978; 17(1):1-10. PubMed ID: 627316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic and immunologic gastrin activity in serum of patients with gastrinoma. Bioassay of gastrin activity in serum.
    Waldum HL; Mignon M; Sandvik AK; Bonfils S
    Scand J Gastroenterol; 1992 Dec; 27(12):1039-44. PubMed ID: 1475620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of terbutaline, a beta 2-adrenoreceptor agonist, on gastric acid secretion and serum gastrin concentrations in humans.
    Thirlby RC; Richardson CT; Chew P; Feldman M
    Gastroenterology; 1988 Oct; 95(4):913-9. PubMed ID: 3410234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zollinger-Ellison syndrome associated with persistently normal fasting serum gastrin concentrations.
    Wolfe MM; Jain DK; Edgerton JR
    Ann Intern Med; 1985 Aug; 103(2):215-7. PubMed ID: 4014903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastrointestinal hormones. I. Hormones of the gastrin group].
    Fritsch WP; Hausamen TU; Scholten T
    Z Gastroenterol; 1977 Apr; 15(4):264-76. PubMed ID: 871064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.